1. Home
  2. ZJYL vs CVM Comparison

ZJYL vs CVM Comparison

Compare ZJYL & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JIN MEDICAL INTERNATIONAL LTD.

ZJYL

JIN MEDICAL INTERNATIONAL LTD.

HOLD

Current Price

$1.93

Market Cap

17.8M

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.25

Market Cap

20.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZJYL
CVM
Founded
2006
1983
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
20.4M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ZJYL
CVM
Price
$1.93
$1.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.0K
335.8K
Earning Date
08-20-2025
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.40
N/A
Revenue Growth
N/A
65.45
52 Week Low
$0.10
$0.89
52 Week High
$4.50
$13.48

Technical Indicators

Market Signals
Indicator
ZJYL
CVM
Relative Strength Index (RSI) 46.73 52.26
Support Level $0.16 $0.95
Resistance Level $2.59 $1.46
Average True Range (ATR) 0.18 0.11
MACD 0.00 0.01
Stochastic Oscillator 14.06 52.78

Price Performance

Historical Comparison
ZJYL
CVM

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: